New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2014
08:36 EDTPTCTPTC Therapeutics named a new top pick at Credit Suisse
Credit Suisse said PTC Therapeutics is a new top pick following the recent CHMP recommendation. The firm expects PTC to launch Translarna in the EU in 2H and and views it as a potential billion-dollar drug. Shares are Outperform rated with a $40 price target.
News For PTCT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 24, 2015
11:37 EDTPTCTPTC Therapeutics CEO no longer owns company shares, TheStreet says
PTC Therapeutics CEO Stu Peltz sold the remaining 47,200 shares he owned in the company, TheStreet's Adam Feuerstein reports, citing a regulatory filing yesterday. The sale follows a stock rise in part fueled by takeover speculation, Feuerstein adds. Reference Link
March 19, 2015
08:11 EDTPTCTPTC Therapeutics and University of Pennsylvania partner for disease research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use